dc.contributor.author
Moreno Pinillos, Rosa
dc.contributor.author
Nolla Solé, Joan Miquel
dc.contributor.author
Juanola, Xavier
dc.contributor.author
Pac Ferraz, Visitación
dc.contributor.author
Vidaller Palacín, Antonio
dc.contributor.author
Moga Sempere, Isabel
dc.date.issued
2012-03-05T12:52:31Z
dc.date.issued
2012-03-05T12:52:31Z
dc.identifier
https://hdl.handle.net/2445/22469
dc.description.abstract
SIR, In the report by Helin et al in the Annals' the authors
suggest that rheumatoid factor (RF) protects against
nephropathy in patients with systemic lupus erythematosus
(SLE).
We have reviewed our series of 78 patients with SLE
fulfilling the criteria of the above report for evaluating
nephropathy and assaying RF. The Waaler-Rose sensitised
sheep cell agglutination test was used to measure RF, with
titres equal or greater than 1/64 considered positive. Both
groups with and without renal disease were comparable for
age and sex. A renal biopsy was performed in 38 out of 40
patients with nephropathy...
dc.format
application/pdf
dc.relation
Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.46.11.877-b
dc.relation
Annals of the Rheumatic Diseases, 1987, vol. 46, núm. 11, p. 877-878
dc.relation
http://dx.doi.org/10.1136/ard.46.11.877-b
dc.rights
(c) BMJ Publishing Group Ltd, 1987
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Clíniques)
dc.subject
Lupus eritematós
dc.subject
Autoanticossos
dc.subject
Lupus erythematosus
dc.subject
Autoantibodies
dc.title
Rheumatoid factor in patients with systemic lupus erythematosus.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion